Edema

• FDA label_change · 2024-01-25
  FDA Approved: ACETAZOLAMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for acetazolamide by Hikma Pharmaceuticals USA Inc., resulting in labeling and/or manufacturing chan…

• FDA label_change · 2015-03-30
  FDA Approved: EDECRIN — Supplemental Application (Bausch Health US, LLC)

  FDA approved a supplemental application for EDECRIN (ethacrynic acid) submitted by Bausch Health US, LLC, updating the drug's labeling.

• FDA label_change · 2013-02-05
  FDA Approved: INDAPAMIDE — Supplemental Application (Actavis Pharma, Inc.)

  FDA approved a supplemental application for indapamide from Actavis Pharma, resulting in labeling changes for the product.

• FDA label_change · 2012-07-11
  FDA Approved: FUROSEMIDE — Supplemental Application (Chartwell RX, LLC)

  FDA approved a supplemental application for furosemide from Chartwell RX, LLC, resulting in changes to the drug's labeling.

• FDA label_change · 2011-03-15
  FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Actavis Pharma, Inc.)

  FDA approved a supplemental application for hydrochlorothiazide, resulting in changes to the product labeling.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.